Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN113149991A details a safer sitagliptin synthesis avoiding DMF and chromatography. Discover cost-effective manufacturing and high-purity supply solutions.
Patent CN1390210A details a novel route to oxazoline intermediates for HIV drugs. Offers improved yield and fewer steps for pharmaceutical manufacturing.
Patent CN100341850C details a novel chiral resolution method for demethylphencynonate salts, enabling >98% optical purity for anti-motion sickness API manufacturing with reduced costs.
Novel 2-step route for Valemetostat intermediate. High purity, scalable process. Cost-effective supply chain solution for oncology drug manufacturing.
Patent CN104761557A reveals efficient synthesis route. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing partners.
Novel chiral Lewis acid process for high-purity diltiazem intermediates. Reduces steps and eliminates expensive reagents for scalable pharmaceutical manufacturing.
Patent CN1445224A details a novel Ru-catalyzed asymmetric transfer hydrogenation process for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.
Advanced acylation method for high-purity cefpirome sulfate. Cost-effective industrial process ensuring stable supply for global pharmaceutical manufacturers.
Novel synthetic route for Trenbolone Acetate reduces cost and waste. Reliable pharmaceutical intermediate supplier offering scalable production.
Patent CN1812990A details a novel Pd/C catalyzed route for famciclovir, achieving superior purity by minimizing hydrolysis impurities through optimized solvent systems.
Patent CN111606923B details a cost-effective 3-step synthesis of racemic clopidogrel using methyl benzoylformate, offering significant supply chain advantages.
Patent CN1293039C reveals a superior method for [(S)-(-)-alpha-methylamino phenylketone]2.(2R,3R)-tartaric acid derivative synthesis, offering enhanced yield and purity for ephedrine production.
Advanced synthesis of Quetiapine Hemifumarate via novel thiosalicylic acid route. High yield, eco-friendly process for cost-effective API manufacturing.
Patent CN1100410A details a novel route for (+)-2-(3,4-dichlorophenyl)-4-hydroxybutylamine using N-methylglucamine resolution and borane reduction for high-purity tachykinin antagonists.
Novel synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Reduces toxicity and improves yield for API manufacturing.
Advanced synthetic route for Quetiapine Hemifumarate using o-bromonitrobenzene. Offers mild conditions, high purity, and cost reduction in API manufacturing.
Patent CN1219756C details a novel Suzuki coupling method using formate additives to suppress dimer impurities, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Novel quinoline kinase inhibitor synthesis offers high yield and purity for pharmaceutical intermediates, ensuring cost reduction and supply chain reliability.
Novel 7-ACA silanization method improves yield and purity significantly. Reduces sewage and drying time for pharmaceutical intermediates manufacturing processes effectively.
Patent CN101979393B details a novel silylation route for cephalothin acid offering high purity and reduced environmental impact for pharmaceutical supply chains.